ZHONG Zi-shao, ZHANG Hai-yan, ZHANG Wang, et al. Effect of Si Junzitang on CaM-MLCK Pathway in Rats with Spleen Deficiency and Gastrointestinal Motility Disorder[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(5): 95-99.
DOI:
ZHONG Zi-shao, ZHANG Hai-yan, ZHANG Wang, et al. Effect of Si Junzitang on CaM-MLCK Pathway in Rats with Spleen Deficiency and Gastrointestinal Motility Disorder[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(5): 95-99. DOI: 10.13422/j.cnki.syfjx.2018050095.
Effect of Si Junzitang on CaM-MLCK Pathway in Rats with Spleen Deficiency and Gastrointestinal Motility Disorder
Objective:To investigate the pathogenesis of gastrointestinal dysfunction (GID) with spleen deficiency syndrome and the intervention effect of Si Junzitang. Method:Totally 36 rats were randomly divided into control group
model group
Si Junzitang group and mosapride group. Iodoacetamide gavage+small platform standing+irregular feeding were used to establish the rat model with spleen deficiency and gastrointestinal dysfunction. After modeling
Si Junzitang (6.3 g·kg-1) and mosapride (0.45 mg·kg-1) were given to intervention groups by gavage; subsequently
gastric emptying detection
Western blot
immunohistochemical staining
Real-time PCR and Mg2+-ATPase activity detection were performed to detect the changes in Calmodulin (CaM)-myosin light chain kinase (MLCK) pathway. Result:Compared with normal group
weight and gastric emptying rate were lower (P<0.01)
and CaM and MLCK protein and mRNA expressions and Mg2+-ATPase activity of gastric antral smooth muscle were higher in model group (P<0.05
P<0.01). Compared with model group
weight and gastric emptying rate were higher (P<0.05)
and CaM and MLCK protein and mRNA expressions and Mg2+-ATPase activity were lower in Si Junzitang group and mosapride group (P<0.05
P<0.01). Conclusion:Rats with spleen deficiency and gastrointestinal dysfunction show CaM-MLCK pathway disorder. Si Junzitang may indirectly improve gastric motility by regulating CaM-MLCK pathway.